Bonvillain Ryan W, Scarritt Michelle E, Pashos Nicholas C, Mayeux Jacques P, Meshberger Christopher L, Betancourt Aline M, Sullivan Deborah E, Bunnell Bruce A
Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine.
J Vis Exp. 2013 Dec 15(82):e50825. doi: 10.3791/50825.
There are an insufficient number of lungs available to meet current and future organ transplantation needs. Bioartificial tissue regeneration is an attractive alternative to classic organ transplantation. This technology utilizes an organ's natural biological extracellular matrix (ECM) as a scaffold onto which autologous or stem/progenitor cells may be seeded and cultured in such a way that facilitates regeneration of the original tissue. The natural ECM is isolated by a process called decellularization. Decellularization is accomplished by treating tissues with a series of detergents, salts, and enzymes to achieve effective removal of cellular material while leaving the ECM intact. Studies conducted utilizing decellularization and subsequent recellularization of rodent lungs demonstrated marginal success in generating pulmonary-like tissue which is capable of gas exchange in vivo. While offering essential proof-of-concept, rodent models are not directly translatable to human use. Nonhuman primates (NHP) offer a more suitable model in which to investigate the use of bioartificial organ production for eventual clinical use. The protocols for achieving complete decellularization of lungs acquired from the NHP rhesus macaque are presented. The resulting acellular lungs can be seeded with a variety of cells including mesenchymal stem cells and endothelial cells. The manuscript also describes the development of a bioreactor system in which cell-seeded macaque lungs can be cultured under conditions of mechanical stretch and strain provided by negative pressure ventilation as well as pulsatile perfusion through the vasculature; these forces are known to direct differentiation along pulmonary and endothelial lineages, respectively. Representative results of decellularization and cell seeding are provided.
可用于满足当前及未来器官移植需求的肺脏数量不足。生物人工组织再生是经典器官移植的一种有吸引力的替代方法。这项技术利用器官天然的生物细胞外基质(ECM)作为支架,在其上接种自体细胞或干/祖细胞,并以促进原始组织再生的方式进行培养。天然ECM通过一种称为去细胞化的过程分离出来。去细胞化是通过用一系列洗涤剂、盐和酶处理组织来实现的,以有效去除细胞物质,同时保持ECM完好无损。利用啮齿动物肺脏的去细胞化及随后的再细胞化进行的研究表明,在生成能够在体内进行气体交换的类肺组织方面仅取得了有限的成功。虽然提供了重要的概念验证,但啮齿动物模型不能直接应用于人类。非人灵长类动物(NHP)提供了一个更合适的模型,可用于研究生物人工器官生产最终用于临床的情况。本文介绍了从恒河猴获取的肺脏实现完全去细胞化的方案。所得的无细胞肺脏可以接种包括间充质干细胞和内皮细胞在内的多种细胞。本文还描述了一种生物反应器系统的开发,在该系统中,接种细胞的猕猴肺脏可以在负压通气以及通过脉管系统进行搏动灌注所提供的机械拉伸和应变条件下进行培养;已知这些力分别引导细胞沿着肺和内皮谱系分化。提供了去细胞化和细胞接种的代表性结果。